Skip to main content
. Author manuscript; available in PMC: 2020 Dec 29.
Published in final edited form as: J Surg Oncol. 2017 Aug 22;117(2):150–159. doi: 10.1002/jso.24808

TABLE 2.

The probability of solitary locoregional recurrence (LRR) or distant recurrence (DR) at 1, 3, 5, and 10 years in patients with locally advanced esophageal cancer treated with neoadjuvant multimodality therapy

LRR, N = 27 DR, N = 140
Probability of recurrence
 1-year 3% 18%
 3-year 6% 27%
 5-year 6% 31%
 10-year 7% 32%
Median time to death after recurrence (months) 8.4 6.1